Cardiovascular effects of the intracerebroventricular injection of adrenomedullin: Roles of the peripheral vasopressin and central cholinergic systems

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 3, 2012, Pages 250-255

  Cam Etoz, B ^a   Isbil Buyukcoskun, N ^a   Ozluk, K ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Adrenomedullin; Atropine; Blood pressure; Mecamylamine; Vasopressin

Indexed keywords

(BETA MERCAPTO BETA BETA CYCLOPENTAMETHYLENEPROPIONYL1, O ME TYROSINE2,ARGININE8)VASOPRESSIN; ADRENOMEDULLIN; ADRENOMEDULLIN[22-52]; ATROPINE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CALCITONIN GENE RELATED PEPTIDE RECEPTOR[8-37]; MECAMYLAMINE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RESPONSE; CHOLINERGIC STIMULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HEART RATE; NONHUMAN; RAT; RECEPTOR BLOCKING;

RATTUS;

EID: 84858427547     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500027     Document Type: Article

References (33)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
2. Wimalawansa SJ. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 1997; 11: 167-239.
3. Joy PH, Supriya K, David MS. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000; 21: 138-167.
4. Hay DL, Conner AC, Howitt SG, Smith DM, Poyner DR. The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J Mol Neurosci 2004; 22: 105-113.
5. Hay DL, Smith DM. Adrenomedullin receptors: molecular identity and function. Peptides 2001; 22: 1753-1763.
6. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994; 340: 226-230.
7. Serrano J, Uttenthal LO, Martinez A, Fernandez AP, de Velasco JM, Alonso D, et al. Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy. Brain Res 2000; 853: 245-268.
8. Ueta Y, Hara Y, Kitamura K, Kangawa K, Eto T, Hattori Y, et al. Action sites of adrenomedullin in the rat brain: functional mapping by Fos expression. Peptides 2001; 22: 1817-1824.
9. Ueta Y, Kitamura K, Isse T, Shibuya I, Kabashima N, Yamamoto S, et al. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci Lett 1995; 202: 37-40.
10. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, et al. Immunocytochemical localization of adrenomedullinlike immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci Lett 1996; 203: 207-210.
11. Fukuhara M, Tsuchihashi T, Abe I, Fujishima M. Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol 1995; 269: R1289-R1293.
12. Shan J, Stachniak T, Jhamandas JH, Krukoff TL. Autonomic and neuroendocrine actions of adrenomedullin in the brain: mechanisms for homeostasis. Regul Pept 2003; 112: 33-40.
13. Takahashi H, Watanabe TX, Nishimura M, Nakanishi T, Sakamoto M, Yoshimura M, et al. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am J Hypertens 1994; 7: 478-482.
14. Saita M, Shimokawa A, Kunitake T, Kato K, Hanamori T, Kitamura K, et al. Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats. Am J Physiol 1998; 274: R979-R984.
15. Samson WK, Murphy TC, Resch ZT. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats. Am J Physiol 1998; 274: R1505-R1509.
16. Shan J, Krukoff TL. Intracerebroventricular adrenomedullin stimulates the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system and production of hypothalamic nitric oxide. J Neuroendocrinol 2001; 13: 975-984.
17. Arslan BY, Ulus IH, Savci V, Kiran BK. Effects of intracerebroventricular injected choline on cardiovascular functions and sympathoadrenal activity. J Cardiovasc Pharmacol 1991; 17: 814-821.
18. Brezenoff HE, Giuliano R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu Rev Pharmacol Toxicol 1982; 22: 341-381.
19. Willette RN, Punnen S, Krieger AJ, Sapru HN. Cardiovascular control by cholinergic mechanisms in the rostral ventrolateral medulla. J Pharmacol Exp Ther 1984; 231: 457-463.
20. Buccafusco JJ. The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol Rev 1996; 48: 179-211.
21. Taylor MM, Baker JR, Samson WK. Brain-derived adrenomedullin controls blood volume through the regulation of arginine vasopressin production and release. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1203-R1210.
22. Isbil-Buyukcoskun N, Gulec G. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin. Regul Pept 2004; 118: 33-38.
23. Smith PM, Ferguson AV. Adrenomedullin acts in the rat paraventricular nucleus to decrease blood pressure. J Neuroendocrinol 2001; 13: 467-471.
24. Ji SM, He RR. Microinjection of adrenomedullin into rostral ventrolateral medulla increases blood pressure, heart rate and renal sympathetic nerve activity in rats. Sheng Li Xue Bao 2002; 54: 460-466.
25. Xu Y, Krukoff TL. Adrenomedullin in the rostral ventrolateral medulla increases arterial pressure and heart rate: roles of glutamate and nitric oxide. Am J Physiol Regul Integr Comp Physiol 2004; 287: R729-R734.
26. Brezenoff HE, Xiao YF. Acetylcholine in the posterior hypothalamic nucleus is involved in the elevated blood pressure in the spontaneously hypertensive rat. Life Sci 1989; 45: 1163-1170.
27. Martin JR. Pressor response to posterior hypothalamic administration of carbachol is mediated by muscarinic M3 receptor. Eur J Pharmacol 1992; 215: 83-91.
28. Scheucher A, Pirola CJ, Balda MS, Dabsys SM, Alvarez AL, Finkielman S, et al. Muscarinic M1 receptors in the lateral septal area mediate cardiovascular responses to cholinergic agonists and bradykinin: supersensitivity induced by chronic treatment with atropine. Neuropharmacology 1987; 26: 181-185.
29. Taira CA, Enero MA. Central muscarinic involvement in cardiovascular control in sinoaortic-denervated rats. Eur J Pharmacol 1989; 159: 265-272.
30. Levey AI, Edmunds SM, Koliatsos V, Wiley RG, Heilman CJ. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J Neurosci 1995; 15: 4077-4092.
31. Buys S, Smih F, Pathak A, Philip-Couderc P, Verwaerde P, Montastruc JL, et al. Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line. Br J Pharmacol 2003; 139: 1219-1227.
32. Saito K, Yoshioka M, Kohya T, Kitabatake A. Involvement of muscarinic M1 receptor in the central pathway of the serotonin-induced Bezold-Jarisch reflex in rats. J Auton Nerv Syst 1994; 49: 61-68.
33. Yokoi H, Arima H, Murase T, Kondo K, Iwasaki Y, Oiso Y. Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rats. Neurosci Lett 1996; 216: 65-67.